ライフサイエンスコーパス: bDNA assay

1 measurements obtained using the single-plex bDNA assay.

2 lasma HIV RNA to less than 500 copies/ml, by bDNA assay.

3 od correlation among LD-PCR, RT-PCR, and the bDNA assay.

4 determined by the Bayer VERSANT HCV RNA 3.0 bDNA assay.

5 NA levels were measured by the branched DNA (bDNA) assay.

6 (PCR) and was quantified by a branched DNA (bDNA) assay.

7 nitor), and Bayer VERSANT HCV RNA 3.0 (Bayer bDNA) assays.

8 gulated blood was not significant after 6 h (bDNA assay, -0.002 log(10) copies/ml; RT-PCR, -0.02 log(

9 2 log(10) copies/ml), but it was after 18 h (bDNA assay, -0.09 log(10) copies/ml; RT-PCR, -0.09 log(1

10 significant (P < 0.05) but small after 6 h (bDNA assay, -0.12 log(10) copies/ml; RT-PCR, -0.05 log(1

11 CR, -0.05 log(10) copies/ml) and after 18 h (bDNA assay, -0.27 log(10) copies/ml; RT-PCR, -0.15 log(1

12 been tested by either a branched DNA probe (bDNA) assay (13 specimens) or a reverse transcription PC

13 CMV was demonstrated in 15 of 16 patients by bDNA assay, 15 of 16 by CMV antigen assay, and 11 of 15

14 study was tested with 2 branched-chain DNA (bDNA) assays, 2 polymerase chain reaction (PCR) assays,

15 brucei complex were chosen as targets of the bDNA assay, a technique which amplifies the signal from

16 The multiplex branched DNA (bDNA) assay adapts the bDNA technology to the Luminex fl

17 The bDNA assay allowed for the highly specific and reproduci

18 gulase-negative Staphylococcus isolates, the bDNA assay and PCR results were 100% concordant.

19 , quantification values obtained with the ES bDNA assay and the first-generation bDNA assay are highl

20 verage processing delay, and were assayed by bDNA assay) and the British Columbia Drug Treatment Prog

21 h the ES bDNA assay and the first-generation bDNA assay are highly correlated, thus allowing for mean

22 sensitivity and specificity of branched DNA (bDNA) assays are derived in part through the judicious d

23 e Quantiplex HCV RNA 2.0 branched-chain DNA (bDNA) assay (Bayer Diagnostics) for hepatitis C viral lo

24 IV RNA/ml) plasma viremia by a commonly used bDNA assay carried integrated proviral DNA and were capa

25 0 greater than those obtained with the Bayer bDNA assay for genotype 1, 2, and 3 samples.

26 0.96 log10 greater than the values for Bayer bDNA assay for samples with genotype 1, 2, or 3 samples

27 The bDNA assay for the quantification of CMV DNA may provide

28 Virus was quantitated using branched DNA (bDNA) assay for both HGV and HCV in the liver explants a

29 than the currently used branched-chain DNA (bDNA) assay for HBV.

30 The VERSANT HCV bDNA Assay has a reportable range of 615 to 7690000 (7.6

31 Changes in CMV DNA levels measured by the bDNA assay in a human immunodeficiency virus-positive pa

32 For the bDNA assays, increasing the cutoff point at which a test

33 The ES bDNA assay is at least 20-fold more sensitive than the f

34 The ES bDNA assay may be useful in determining the prognostic v

35 tectable hepatitis B virus (HBV) DNA (by the bDNA assay) pretreatment were significantly associated w

36 Thus, the multiplex bDNA assay provides a powerful means to quantify the gen

37 The branched-DNA (bDNA) assay provides a reliable method for the quantific

38 these samples, measured by an ultrasensitive bDNA assay (Quantiplex HIV RNA assay version 3.0; Chiron

39 ng <500 HIV RNA copies/ml in a branched-DNA (bDNA) assay (Quantiplex HIV RNA assay version 2.0 [Chiro

40 Plasma viremia, as measured by branched-DNA (bDNA) assay, reached a peak at 2 weeks postinoculation b

41 rated into the enhanced-sensitivity bDNA (ES bDNA) assay to reduce the background level and enhance t

42 Branched DNA (bDNA) assays to quantify human immunodeficiency virus ty

43 the branched DNA signal amplification assay (bDNA assay) to quantitatively measure the mRNA levels fo

44 justing for CD4(+)-cell count and converting bDNA assay values to those corresponding to the RT-PCR r

45 In the present study, the HIV-1 bDNA assay was adapted for viral lysis in the System 340

46 Furthermore, the bDNA assay was at least as sensitive as culture techniqu

47 A branched-DNA (bDNA) assay was developed for the reliable quantificatio

48 -PCR and RT-PCR were more sensitive than the bDNA assay when the HCV titer was low.

49 developed to enhance the sensitivity of the bDNA assay while maintaining its performance characteris

50 old more sensitive than the first-generation bDNA assay, yet it maintains a high level of accuracy, l